NAM
TECH icon

Nexpoint Asset Management’s Bio-Techne TECH Stock Holding History

Nexpoint Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,000
Closed -$2.64M – 208
2020
Q2 		$2.64M Buy
+40,000
New +$2.4M 0.6% 31

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nexpoint Asset Management's TECH Position: Q3 2020 in Review

Nexpoint Asset Management sold out of Bio-Techne (TECH) in Q3 2020, closing a stake of 40,000 shares — an estimated $2.64M sold.

Nexpoint Asset Management first reported a position in TECH in Q2 2020 and held it in 1 quarter. The position peaked at $2.64M in Q2 2020. 418 funds tracked by Wall St. Rank hold TECH as of Q3 2020.

  • Nexpoint Asset Management reported no remaining Bio-Techne position as of Q3 2020 after selling out during the quarter.
  • Nexpoint Asset Management sold 40,000 Bio-Techne shares in Q3 2020, an estimated $2.64M.
  • Nexpoint Asset Management first reported a position in Bio-Techne in Q2 2020 and held it in 1 quarter.
  • Nexpoint Asset Management's Bio-Techne position peaked at $2.64M in Q2 2020.
  • 418 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2020.

Based on Nexpoint Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.